184 related articles for article (PubMed ID: 8790372)
1. Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model.
Santoni-Rugiu E; Preisegger KH; Kiss A; Audolfsson T; Shiota G; Schmidt EV; Thorgeirsson SS
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9577-82. PubMed ID: 8790372
[TBL] [Abstract][Full Text] [Related]
2. Transgenic mouse models in carcinogenesis: interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis.
Thorgeirsson SS; Santoni-Rugiu E
Br J Clin Pharmacol; 1996 Jul; 42(1):43-52. PubMed ID: 8807143
[TBL] [Abstract][Full Text] [Related]
3. Interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis.
Thorgeirsson SS; Santoni-Rugiu E
Mutat Res; 1997 May; 376(1-2):221-34. PubMed ID: 9202759
[TBL] [Abstract][Full Text] [Related]
4. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
[TBL] [Abstract][Full Text] [Related]
5. Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformation.
Amicone L; Terradillos O; Calvo L; Costabile B; Cicchini C; Della Rocca C; Lozupone F; Piacentini M; Buendia MA; Tripodi M
Oncogene; 2002 Feb; 21(9):1335-45. PubMed ID: 11857077
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibition and induction of apoptosis by HGF in transformed rat liver epithelial cells.
Conner EA; Wirth PJ; Kiss A; Santoni-Rugiu E; Thorgeirsson SS
Biochem Biophys Res Commun; 1997 Jul; 236(2):396-401. PubMed ID: 9240448
[TBL] [Abstract][Full Text] [Related]
7. Hepatic tumor induction in c-myc mono-transgenic and TGF-alpha/c-myc double-transgenic mice.
Thorgeirsson SS; Santoni-Rugiu E; Davis CD; Snyderwine EG
Arch Toxicol Suppl; 1997; 19():359-66. PubMed ID: 9079223
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers.
Sakata H; Takayama H; Sharp R; Rubin JS; Merlino G; LaRochelle WJ
Cell Growth Differ; 1996 Nov; 7(11):1513-23. PubMed ID: 8930401
[TBL] [Abstract][Full Text] [Related]
9. Phenobarbital causes apoptosis in conditionally immortalized mouse hepatocytes depending on deregulated c-myc expression: characterization of an unexpected effect.
Osanai M; Ogawa K; Lee GH
Cancer Res; 1997 Jul; 57(14):2896-903. PubMed ID: 9230198
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of apoptosis by c-myc in transgenic hepatocytes and effects of growth factors and nongenotoxic carcinogens.
Christensen JG; Goldsworthy TL; Cattley RC
Mol Carcinog; 1999 Aug; 25(4):273-84. PubMed ID: 10449034
[TBL] [Abstract][Full Text] [Related]
11. Promotion of hepatocarcinogenesis by phenobarbital in c-myc/TGF-alpha transgenic mice.
Sanders S; Thorgeirsson SS
Mol Carcinog; 2000 Jul; 28(3):168-73. PubMed ID: 10942533
[TBL] [Abstract][Full Text] [Related]
12. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS
Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine.
Horiguchi N; Takayama H; Toyoda M; Otsuka T; Fukusato T; Merlino G; Takagi H; Mori M
Oncogene; 2002 Mar; 21(12):1791-9. PubMed ID: 11896611
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor in transgenic mice.
Shiota G; Kawasaki H
Int J Exp Pathol; 1998 Oct; 79(5):267-77. PubMed ID: 10193310
[TBL] [Abstract][Full Text] [Related]
15. Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice.
Factor VM; Kao CY; Santoni-Rugiu E; Woitach JT; Jensen MR; Thorgeirsson SS
Cancer Res; 1997 Jun; 57(11):2089-95. PubMed ID: 9187100
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of hepatocyte growth factor on metastasis of hepatocellular carcinoma in transgenic mice.
Shiota G; Kawasaki H; Nakamura T; Schmidt EV
Res Commun Mol Pathol Pharmacol; 1996 Jan; 91(1):33-9. PubMed ID: 8824929
[TBL] [Abstract][Full Text] [Related]
17. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis.
Murakami H; Sanderson ND; Nagy P; Marino PA; Merlino G; Thorgeirsson SS
Cancer Res; 1993 Apr; 53(8):1719-23. PubMed ID: 8467484
[TBL] [Abstract][Full Text] [Related]
18. MYC-regulated genes involved in liver cell dysplasia identified in a transgenic model of liver cancer.
Hunecke D; Spanel R; Länger F; Nam SW; Borlak J
J Pathol; 2012 Dec; 228(4):520-33. PubMed ID: 22653869
[TBL] [Abstract][Full Text] [Related]
19. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.
Calvisi DF; Factor VM; Loi R; Thorgeirsson SS
Cancer Res; 2001 Mar; 61(5):2085-91. PubMed ID: 11280770
[TBL] [Abstract][Full Text] [Related]
20. Minimal cooperation between mutant Hras and c-myc or TGFα in the regulation of mouse hepatocyte growth or transformation in vivo.
Stein TJ; Bowden M; Sandgren EP
Liver Int; 2011 Oct; 31(9):1298-305. PubMed ID: 22093452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
